Breakthroughs
Personalized mRNA Cancer Vaccine Cuts Melanoma Recurrence in Landmark Trial
A Landmark Moment in Cancer Treatment Drugmakers Moderna and Merck have announced that a personalized mRNA cancer vaccine, given alongside the immunotherapy drug Keytruda, significantly...